Search Results 841-850 of 16409 for monoclonal antibody

  1. Phase II Single-arm Study of Tepotinib Combined with Cetuximab - Mayo Clinic

    ... antibody targeted therapy due to mesenchymal epithelial transition factor (MET) amplification. ... monoclonal antibody therapy (panitumumab or cetuximab) ...

  2. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Chemotherapy, small molecule inhibitors, radiation, and/or other investigational anticancer agents (excluding investigational monoclonal antibodies): within 2 ...

  3. Stopping Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients - Mayo Clinic

    Other Monoclonal Antibodies: Subjects who have received any monoclonal antibody (other than XOLAIR®) to treat inflammatory disease within 5 half-lives of Visit ...

  4. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

    - History of severe hypersensitivity to another monoclonal antibody - Other concurrent cancer or a history of another invasive malignancy within the last 3

  5. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

    * Monoclonal gammopathy of undetermined significance ... * Known allergies, hypersensitivity, or intolerance to corticosteroids, monoclonal antibodies ...

  6. Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization - Mayo Clinic

    About this study. The purpose of this trial is to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in ...

  7. Seroprevalence Study of Pre-existing Immunity for Adenovirus-associated Virus Vector in MYBPC3-associated Hypertrophic Cardiomyopathy - Mayo Clinic

    Currently receiving systemic immunosuppressive therapy, cytotoxic chemotherapy, immunoglobulin therapy, or monoclonal antibody therapy. History of ...

  8. Chemotherapy nausea and vomiting: Prevention is best defense - Mayo Clinic

    Monoclonal antibody drugs · Mort Crim and Cancer · Mouth cancer · What is mouth cancer? A Mayo Clinic expert explains · Mouth cancer FAQs · Mouth sores caused ...

  9. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

    Prior treatment with a monoclonal antibody within 4 weeks prior to ... Known or suspected hypersensitivity to monoclonal antibodies; Currently ...

  10. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

    ... monoclonal antibody (mAb) and for which no other more appropriate treatment option exists; At least one bidimensionally measurable lesion; Agreement to remain ...